@JackNdreu It’s okay! People should take profit at whatever level satisfies them. Institutional $ will come in consistently along the way, so no harm at all.
@joeretired41 It’s so easy to see through. One last BIG smear campaign, well coordinated before approval and before court ruling to allow evidence. Load up and enjoy!
Actor David Spade just exposed something insane in California…
A bipartisan bill was introduced to audit where $20+ BILLION in “missing” homeless funding went.
It passed.
But, then Gavin Newsom vetoed it to block the investigation.
He's also vetoed similar audit bills: AB 2570 & AB 2093
@michael_bloser Fair critique and definitely disappointing. Objectively, a definite struggle, but no startup company goes perfectly in the early days and honesty is the most important policy here. Progress on several other fronts, which is very good and likely offsets.
$NWBO Mark this down. This company and its string of successes and bio technology will create one of the biggest (top 5) short squeezes in stock market history. It’s bottled up.
@andrewcaravello Understand this, and you will understand the immense power of $NWBO long-term. There is no short seller or MM in the world that can mask this power once unleashed.
@ajw02360@METhompson72@jaygreco194737 Finally, there needs to be a presumption that all of this is being aligned in proper order, and that behind the scenes, the regulation discussions, pricing, supply chain, litigation - everything is strategic in the end. It is a grandmaster playbook.
@ajw02360@METhompson72@jaygreco194737 Of course you will find some people that are intolerable to any negativity. Much like you will find the exact opposite, which is the buffoons on the short side that know nothing about this technology or industry and are simply bashing. The 90% in the middle understand both sides.
@ajw02360@METhompson72@jaygreco194737 I think this is a tremendously unfair critique. Those who believe in the $10-$30+ range understand the science, the repeatability, and the overall market sizing. They understand the lead that $NWBO is currently in relative to trial data and supply chain.
@Tiggersdad2@AndresL04854206@jaygreco194737 Kind of simple, actually. You have no basis for your argument, and it appears through your writing as though you are about as uninformed as the bots that exist in X land. If your allegations were rooted in science, or you had some reasonable defense to the position, fine. But…
I wrote an article about $NWBO:
https://t.co/sOhaEsuQJU
I encourage everyone to read it. What is happening with NWBO is astounding and our persistent retail investor has hung on through it all.
I believe we will all be much better off when this story comes to its' ending.